ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS

OBJECTIVES: In Japan, when bevacizumab was approved for malignant glioma patients in 2013, there were limited data on Japanese patients. In the global P3 AVAglio study, the incidence of cerebral hemorrhage, including tumor-related bleeding, and infections was higher in patients who received bevacizu...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neuro Oncol
Main Authors: Nishikawa, Ryo, Nagane, Motoo, Shimizu, Ayaka, Tamura, Takashi, Ura, Masako
格式: Artigo
語言:Inglês
出版: Oxford University Press 2017
主題:
Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692943/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.029
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍